✦ LIBER ✦

Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial

✍ Scribed by Harry D. Bear; John Roberts; David Cornell; Mary Beth Tombes; Brenda Kyle

Book ID: 105968465
Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 100 KB
Volume: 50
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s002620100199

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy of adoptive immunother

Clinical efficacy of adoptive immunotherapy by IL-4 activated tumor-infiltrating lymphocytes in patients with advanced cancer

✍ Takuya Tsunoda; Hiroshi Tanimura; Hiroki Yamaue; Makoto Iwahashi; Masaji Tani; K 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 491 KB

The use of BRM-activated killer cells in

The use of BRM-activated killer cells in adoptive immunotherapy: A pilot study with nine advanced cancer patients

✍ Takusaburo Ebina; Yoshiaki Fujimiya; Tomohiro Yamaguchi; Naoko Ogama; Hiroko Sas 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 343 KB

A Pilot Study of Laparoscopic Extraperit

A Pilot Study of Laparoscopic Extraperitoneal Lymph Node Dissection in Patients With Locally Advanced Cervical Cancer: A Trial Design Report

✍ Michael J. Worley Jr.; Robert L. Coleman; Michael Frumovitz; Anuja Jhingran; Mar 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 708 KB

171 Strategy to augment the efficacy of

171 Strategy to augment the efficacy of immunotherapy for refractory breast cancer: a pilot clinical study of adoptive cell therapy combined with trastuzumab

✍ N. Seki; U. Toh; T. Fujii; S. Nakagawa; H. Otsuka; K. Shirouzu; H. Yamana 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

A Phase-II Clinical Trial of Laparoscopy

A Phase-II Clinical Trial of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Gastric Cancer Patients

✍ Jun Ho Lee; Young-Woo Kim; Keun Won Ryu; Jong Ryul Lee; Chan Gyoo Kim; Il Ju Cho 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 207 KB

A randomized trial of adoptive immunothe

A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer

✍ Giovanni B. Ratto; Paolo Zino; Sandro Mirabelli; Paolo Minuti; Riccardo Aquilina 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

A previous pilot study from our group suggested that: (1) adoptive immunotherapy (AI) with tumor-infiltrating lymphocytes (TIL) and recombinant interleukin-2 (rIL-2) may be applied with safety to more than 80% of the patients who had surgery for Stage 111 nonsmall cell lung carcinoma (NSCLC); and (2